Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:29
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Rate of Peritoneal Carcinomatosis in Resected Stage II and III Colon Cancer
    Choi, Audrey H.
    Farzaneh, Cyrus
    Kejriwal, Nidhi
    Calidas, Aashna
    Cordero-Caban, Kathia
    Roman, Melanie
    Kwong, Mei Li M.
    Selleck, Matthew J.
    Pigazzi, Alessio
    Jafari, Dorna
    Senthil, Maheswari
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 4943 - 4948
  • [32] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [33] The impact of time to surgery on oncological outcomes in stage I-III dMMR colon cancer - A nationwide cohort study
    Justesen, Tobias Freyberg
    Gogenur, Mikail
    Clausen, Johan Stub Rono
    Mashkoor, Maliha
    Rosen, Andreas Weinberger
    Gogenur, Ismail
    EJSO, 2023, 49 (09):
  • [34] Prognostic value of circulating cytokines for stage III colon cancer
    Lee, Won-Suk
    Baek, Jeong-Heum
    You, Dong Hun
    Nam, Myeong Jin
    JOURNAL OF SURGICAL RESEARCH, 2013, 182 (01) : 49 - 54
  • [35] Post-operative Aspirin Use and Colorectal Cancer-specific Survival in Patients with Stage I-III Colorectal Cancer
    Goh, Hin Hock
    Leong, Wei Qi
    Chew, Min Hoe
    Pan, Yihui Summer
    Tony, Lim Kiat Hon
    Chew, Lita
    Tan, Iain Bee Huat
    Toh, Han Chong
    Tang, Choong Leong
    Fu, Wan Pei Cherylin
    Chia, Whay Kuang
    ANTICANCER RESEARCH, 2014, 34 (12) : 7407 - 7414
  • [36] The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients
    Zhou, Chenghui
    Lu, Liqing
    Huang, Qiulin
    Tang, Zhen
    Tang, Rong
    Xiao, Zhongsheng
    Xiao, Shuai
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [37] Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
    Tarantino, I.
    Warschkow, R.
    Worni, M.
    Merati-Kashani, K.
    Koeberle, D.
    Schmied, B. M.
    Mueller, S. A.
    Steffen, T.
    Cerny, T.
    Gueller, U.
    BRITISH JOURNAL OF CANCER, 2012, 107 (02) : 266 - 274
  • [38] Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients
    Lee, Dong Hee
    Jo, Il
    Lee, Hye Sun
    Kang, Jeonghyun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (06) : 2908 - 2915
  • [39] Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression
    Jiang, Huihong
    Tang, Erjiang
    Chen, Ying
    Liu, Hailong
    Zhao, Yun
    Lin, Moubin
    He, Luwei
    CANCER SCIENCE, 2022, 113 (03) : 971 - 985
  • [40] Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection
    Yih-Huei Uen
    Chien-Yu Lu
    Hsiang-Lin Tsai
    Fang-Jung Yu
    Ming-Yii Huang
    Tian-Lu Cheng
    Shiu-Ru Lin
    Jaw-Yuan Wang
    Annals of Surgical Oncology, 2008, 15